Skip to content

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02137902
Acronym
HEALTHH
Enrollment
299
Registered
2014-05-14
Start date
2015-06-01
Completion date
2020-03-31
Last updated
2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Dependence

Keywords

Tobacco dependence, Cardiovascular disease, Risk behaviors, Smoking, Physical activity, Alaska Native people

Brief summary

This study aims to identify effective and cost-effective interventions for tobacco use and other risk behaviors for cardiovascular disease among Alaska Native people in rural villages. In a randomized controlled trial, the study will compare interventions using telemedicine to promote the American Heart Association's identified ideal health behaviors (nonsmoking and physical activity) relative to ideal health factors (managing cholesterol and blood pressure).

Detailed description

In an RCT, we will compare 2 active treatments delivered over 12-months via telehealth services linking participants in rural villages to Anchorage and Stanford-based study counselors overcoming access-to-care for CV preventive health issues. The village AN health aides will facilitate data collection and telehealth connectivity. Intervention contacts occur at baseline, 3-, 6- and 12-months follow-up, with the final assessment at 18-months. The repeated intervention contacts provide iterative computerized feedback reflecting prior responses and encouragement of adoption and maintenance of behavioral health goals. The groups are: 1. Tobacco/Physical Activity Intervention (n=150), consisting of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program. The study will provide 12-weeks of NRT for participants randomized to this intervention condition. 2. HTN/HCL (HTN/HC, n=150), consisting of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. The AN health plan covers antihypertensive and statins as a benefit to patients and would be prescribed as part of standard of care (i.e., not prescribed for the purposes of this research); however, strategies to maximize medication adherence are needed, hence the focus of this intervention. The counseling and print materials are highly individualized, unique to the participant, thereby minimizing the likelihood of cross-condition contamination, determined to be minimal in prior investigations. For the research study, participant eligibility criteria include AN heritage; daily cigarette smoking; and hypertension, hyperlipidemia, or established vascular disease. Intention to change the targeted risk behaviors will not be required to participate. Utilizing telemedicine technology and Transtheoretical Model-tailored interventions, the trial aims to reach at-risk AN people regardless of residential location or current motivation. The primary outcome is biochemically-confirmed tobacco abstinence using anabasine. Secondary outcomes include moderate-to-vigorous physical activity assessed by self-report, blood pressure, cholesterol ratio, medication adherence, dietary change, body mass index, Framingham index, multibehavioral impact factor, a linear index, and cost effectiveness.

Interventions

BEHAVIORALTobacco/Physical Activity Intervention

Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation and goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program.

BEHAVIORALDiet plus BP/CHOL Intervention

Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. Includes a native diet cookbook and medication bag.

Sponsors

University of California, San Francisco
CollaboratorOTHER
Alaska Native Tribal Health Consortium
CollaboratorOTHER
University of Alaska Anchorage
CollaboratorOTHER
Norton Sound Health Corporation
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Smoking \> 5 cigarettes/day and \> 100 cigarettes in one's lifetime * Hypertension, hypercholesterolemia, or established vascular disease * Fluent in English language

Exclusion criteria

* Dementia or other brain injury * Pregnancy or breastfeeding * Currently engaged in tobacco treatment or using cessation pharmacotherapy

Design outcomes

Primary

MeasureTime frameDescription
Smoking Status: 7-day point prevalence abstinenceAssessed at baseline, 3, 6, 12, and 18 monthsChange from baseline as no tobacco use, including a puff, in the past 7 days

Secondary

MeasureTime frameDescription
Blood pressureAssessed at baseline, 3, 6, 12, and 18 monthsMeasured as systolic/diastolic in mmHg
Total, LDL, and HDL cholesterolAssessed at baseline and 18 monthsmeasured in milligrams per deciliter of blood (mg/dL)
Body Mass Index (BMI)Assessed at baseline, 3, 6, 12, and 18 monthsweight (in kilograms) over height squared (in centimeters)
Framingham Risk Factor ScoreAssessed at baseline and 18 monthsgender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual
Minutes of moderate-to-vigorous physical activity in past 7 daysAssessed at baseline, 3, 6, 12, and 18 monthsself-reported minutes of moderate-to-vigorous physical activity
Dietary QualityAssessed at baseline, 3, 6, 12 and 18 monthsculturally tailored FFQ assessing consumption of native and non-native foods
Multiple Risk Behavior Change Impact FactorAssessed at baseline, 3, 6, 12 and 18 monthsintervention efficacy times participation summed over the multiple behavioral targets, I = ∑# of behaviors(n) (En × Pn)
Linear index of multiple behavior changeAssessed at baseline, 3, 6, 12 and 18 monthscomputed by subtracting baseline scores from follow-up scores for each risk behavior, dividing by the standard deviation of the difference (i.e., z-score), and summing across the individual risks (smoking, exercise, diet, adherence)
Medication AdherenceAssessed at baseline, 3, 6, 12 and 18 monthsself-reported assessment of adherence to BP and CHOL meds

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026